A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
NCT04312308
·
clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Interventions
OTHER:
Sample collection
Sponsor
Yonsei University